Product analysis
OptiStatin CoQ10-SR combines CoQ10 with vitamins and selenium, with limited evidence linking CoQ10 to blood-vessel function. The unspecified CoQ10 preparation makes comparison with the preparations behind those findings harder.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality62
Selenium has a clearly identified form, while the CoQ10 preparation is unspecified. Vitamin K is described as K2 with more specific information pointing to MK-7, but its identity is not consistently clear.
Ingredient Transparency91
The listed amounts are disclosed, helping compare servings. Several preparations remain unspecified, limiting a more precise comparison.
Value For Money34
Selenium and vitamin K compare poorly on cost, while CoQ10 offers limited value. Vitamin D value remains uncertain, so the combination has no clear price advantage.
Customer Satisfaction71
Customer ratings are generally positive within a small review base. The feedback does not establish effectiveness or safety.
Product Focus75
CoQ10 has limited links to selected measures of blood-vessel function, while the vitamins and selenium mainly contribute to normal nutrition. These roles do not establish an added benefit from combining the ingredients.
- Format
Capsule - Container
- 30 Vegicap(s)
- Per serving
- $0.79
- Customer rating
- 4.7 · 84 ratings
Goals
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin D3 (Cholecalciferol) | 50 mcg | |
Selenium (L-Selenomethionine) | 200 mcg | |
Coenzyme Q10 | 100 mg | |
MenaQ7 (Vitamin K2) | 180 mcg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
Selenium Chemical Form
Form Transparency & Isomer Specificity
Dose, Safety & Label Transparency100
Dosage Efficacy Sweet Spot
Safety Margin & UL Adherence
Value30
Price per 200 mcg Serving
How this ingredient is rated
Active Ingredient Quality & Bioavailability82
Vitamin K Form (MK-7 vs. MK-4 vs. K1)
MK-7 Isomer Disclosure
Dose, Safety & Label Transparency82
Vitamin K2 (MK-7) Dosage Efficacy
Form and Subtype Transparency
Value20
Price per Effective MK-7 Serving
How this ingredient is rated
Active Ingredient Quality & Bioavailability12
Molecular Form: Ubiquinol vs. Ubiquinone
Formulation & Absorption Enhancers
Dose, Safety & Label Transparency72
Clinical Dosage Alignment
Label Transparency & Fillers
Value40
Price Per Effective Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial.
- Vitamin D analogs and bone: preclinical and clinical studies with eldecalcitol.
- Efficacy of vitamin D fortified foods on bone mineral density and serum bone biomarkers: A systematic review and meta-analysis of interventional studies.
- Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial.
- Vitamin D supplementation and bone health in post-menopausal women: a 24-month randomized controlled intervention with enhanced bioavailability formulations.
- Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
- Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
- Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
- Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
- Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Effect of supplementation with high-selenium yeast on plasma lipids: a randomized trial.
- Association of selenium and cadmium with heart failure and mortality based on the National Health and Nutrition Examination Survey.
- Higher serum selenium concentration is associated with lower risk of all-cause and cardiovascular mortality among individuals with chronic kidney disease: A population-based cohort study of NHANES.
- Selenium status in the body and cardiovascular disease: a systematic review and meta-analysis.
- Associations of selenium status with all-cause and cause-specific mortality: a systematic review and meta-analysis of cohort studies.